Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews...
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • Allergy (Apr 2019)
    • Biology of familial cancer predisposition syndromes (Feb 2019)
    • Mitochondrial dysfunction in disease (Aug 2018)
    • Lipid mediators of disease (Jul 2018)
    • Cellular senescence in human disease (Apr 2018)
    • View all review series...
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Scientific Show Stoppers
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Current issue
  • Past issues
  • By specialty
  • Subscribe
  • Alerts
  • Advertise
  • Contact
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • Brief Reports
  • Technical Advances
  • Commentaries
  • Editorials
  • Hindsight
  • Review series
  • Reviews
  • The Attending Physician
  • First Author Perspectives
  • Scientific Show Stoppers
  • Top read articles
  • Concise Communication
Schwann cells expressing nociceptive channel TRPA1 orchestrate ethanol-evoked neuropathic pain in mice
Francesco De Logu, … , Pierangelo Geppetti, Romina Nassini
Francesco De Logu, … , Pierangelo Geppetti, Romina Nassini
Published December 2, 2019; First published September 5, 2019
Citation Information: J Clin Invest. 2019;129(12):5424-5441. https://doi.org/10.1172/JCI128022.
View: Text | PDF
Categories: Research Article Neuroscience

Schwann cells expressing nociceptive channel TRPA1 orchestrate ethanol-evoked neuropathic pain in mice

  • Text
  • PDF
Abstract

Excessive alcohol consumption is associated with spontaneous burning pain, hyperalgesia, and allodynia. Although acetaldehyde has been implicated in the painful alcoholic neuropathy, the mechanism by which the ethanol metabolite causes pain symptoms is unknown. Acute ethanol ingestion caused delayed mechanical allodynia in mice. Inhibition of alcohol dehydrogenase (ADH) or deletion of transient receptor potential ankyrin 1 (TRPA1), a sensor for oxidative and carbonyl stress, prevented allodynia. Acetaldehyde generated by ADH in both liver and Schwann cells surrounding nociceptors was required for TRPA1-induced mechanical allodynia. Plp1-Cre Trpa1fl/fl mice with a tamoxifen-inducible specific deletion of TRPA1 in Schwann cells revealed that channel activation by acetaldehyde in these cells initiates a NADPH oxidase-1–dependent (NOX1-dependent) production of hydrogen peroxide (H2O2) and 4-hydroxynonenal (4-HNE), which sustains allodynia by paracrine targeting of nociceptor TRPA1. Chronic ethanol ingestion caused prolonged mechanical allodynia and loss of intraepidermal small nerve fibers in WT mice. While Trpa1–/– or Plp1-Cre Trpa1fl/fl mice did not develop mechanical allodynia, they did not show any protection from the small-fiber neuropathy. Human Schwann cells express ADH/TRPA1/NOX1 and recapitulate the proalgesic functions of mouse Schwann cells. TRPA1 antagonists might attenuate some symptoms of alcohol-related pain.

Authors

Francesco De Logu, Simone Li Puma, Lorenzo Landini, Francesca Portelli, Alessandro Innocenti, Daniel Souza Monteiro de Araujo, Malvin N. Janal, Riccardo Patacchini, Nigel W. Bunnett, Pierangelo Geppetti, Romina Nassini

×

Figure 5

Acetaldehyde via TRPA1 generates ROS that sustain ethanol-evoked allodynia.

Options: View larger image (or click on image) Download as PowerPoint
Acetaldehyde via TRPA1 generates ROS that sustain ethanol-evoked allodyn...
(A) H2O2 levels (hind paw) after ethanol (EtOH, i.g. or i.pl.). (B) 4-HNE staining (plantar nerve) and levels (hind paw) after i.g. EtOH. (C) Mechanical allodynia evoked by EtOH (i.g.) or vehicle (Veh) after N-acetylcysteine (NAC; 250 mg/kg, i.p.) and PBN (50 mg/kg, i.p.) or their Veh. (D and E) H2O2 levels (hind paw) after i.g. and i.pl. EtOH or Veh in mice pretreated with 4-Mp (50 mg/kg, i.g.) (D), A967079 (A96, 100 mg/kg, i.p.), and PBN (100 mg/kg, i.p.) (E) or their Veh. (F) H2O2 levels (hind paw) after acetaldehyde (ACD; 0.1 mg/kg, i.p., or 10 nmol, i.pl.). (G) H2O2 levels (hind-paw tissue) after ACD (0.1 mg/kg, i.p., or 10 nmol, i.pl.) or Veh and pretreatment with A96 (100 mg/kg, i.p.) or PBN (100 mg/kg, i.p.) or their Veh. (H) H2O2 levels (hind paw) in Trpa1+/+ and Trpa1–/– mice treated with i.g. and i.pl. EtOH (H), ACD (0.1 mg/kg, i.p., and 10 nmol, i.pl.) (I), or their Veh. BL, baseline. Veh is the vehicle of EtOH and ACD. Where not indicated, mice are C57BL/6J and EtOH doses are: i.g., 15%, 4 mL/kg, and i.pl., 30%, 20 μL. (B, 4-HNE mean gray value) Box plots with horizontal lines at the 25th percentile, the median, and the 75th percentile and vertical lines that extend to the minimum and maximum values; all other data are mean ± SEM with individual data points overlaid; n = 6–8 mice for each experimental condition. *P < 0.05, **P < 0.01, ***P < 0.001 vs. Veh, ACD-BL, and H2O2-BL; §P < 0.05, §§§P < 0.001 vs. EtOH, EtOH-A96, EtOH-PBN, EtOH-Trpa1+/+, ACD-A96, ACD-PBN, and ACD-Trpa1+/+; 1-way (A, B, and D–I) or 2-way (C) ANOVA with Bonferroni post hoc correction.
Follow JCI:
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts